Volume 28 Issue 2, February 2003

A Neurochemically Distinct Dorsal Raphe-Limbic Circuit with a Potential Role in Affective Disorders

• Kathryn G Commons
• K Ryan Connolley
• Rita J Valentino

Preclinical Research 09 Aug 2002

Nicotine Induces Glutamate Release from Thalamocortical Terminals in Prefrontal Cortex

• Evelyn K Lambe
• Marina R Picciotto
• George K Aghajanian

Preclinical Research 14 Feb 2003

Sensitivity to Sensorimotor Gating-Disruptive Effects of Apomorphine in two Outbred Parental Rat Strains and their F1 and N2 Progeny

• Neal R Swerdlow
• Amanda Platten
• Pamela Auerbach

Preclinical Research 14 Feb 2003

Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model

• Martin E Keck
• Tobias Welt
• Rainer Landgraf

Clinical Research 25 Jul 2002

Imaging Brain Phospholipase A₂ Activation in Awake Rats in Response to the 5-HT_2A/2C Agonist (±)2,5-Dimethoxy-4-Iodophenyl-2-Aminopropane (DOI)

• Ying Qu
• Lisa Chang
• Stanley I Rapoport

Preclinical Research 05 Jun 2002

Selective 5-HT_1A Antagonists WAY 100635 and NAD-299 Attenuate the Impairment of Passive Avoidance Caused by Scopolamine in the Rat

• Ilga Misane
• Sven Ove Ögren

Preclinical Research 14 Feb 2003

Induction of Metabolic Hypofunction and Neurochemical Deficits after Chronic Intermittent Exposure to Phencyclidine: Differential Modulation by Antipsychotic Drugs

• Susan M Cochran
• Matthew Kennedy
• Brian J Morris

Preclinical Research 14 Feb 2003

Inhibition of 5-HT Neurotransmission Increases Clonidine Protective Effects on Naloxone-induced Conditioned Place Aversion in Morphine-dependent Rats

• Stéphanie Caillé
• Luis Stinus
• George F Koob

Preclinical Research 15 Jul 2002

Apomorphine Enhances Conditioned Responses Induced by Aversive Stimulation of the Inferior Colliculus

• Ana Cristina Troncoso
• Mario Yukio Osaki
• Marcus Lira Brandão

Preclinical Research 14 Feb 2003

Enhanced Morphine Preference Following Prolonged Abstinence: Association with Increased Fos Expression in the Extended Amygdala

• Glenda C Harris
• Gary Aston-Jones

Preclinical Research 14 Feb 2003

Differential Effects of Haloperidol, Risperidone, and Clozapine Exposure on Cholinergic Markers and Spatial Learning Performance in Rats

• Alvin V Terry Jr
• William D Hill
• Sahebarao P Mahadik

Preclinical Research 25 Jul 2002

Zaprinast, a Phosphodiesterase 5 Inhibitor, Overcomes Sexual Dysfunction Produced by Fluoxetine, a Selective Serotonin Reuptake Inhibitor in Hamsters

• Cheryl A Frye
• Madeline E Rhodes

Preclinical Research 14 Feb 2003

Long-Lasting Changes in Morphine-Induced Locomotor Sensitization and Tolerance in Long-Evans Mother Rats as a Result of Periodic Postpartum Separation from the Litter: A Novel Model of Increased Vulnerability to Drug Abuse?

• Mikhail Kalinichev
• Keith W Easterling
• Stephen G Holtzman

Preclinical Research 20 Sept 2002

Attenuation of Cue-Controlled Cocaine-Seeking by a Selective D₃ Dopamine Receptor Antagonist SB-277011-A

• Patricia Di Ciano
• Rachel J Underwood
• Barry J Everitt

Preclinical Research 18 Jun 2002

Acute changes in Cerebrospinal Fluid 5-HIAA following Oral Paroxetine Challenge in Healthy Humans

• Linda L Carpenter
• George M Anderson
• Lawrence H Price

Clinical Research 14 Feb 2003

State Markers of Depression in Sleep EEG: Dependency on Drug and Gender in Patients Treated with Tianeptine or Paroxetine

• H Murck
• T Nickel
• F Holsboer

Clinical Research 14 Feb 2003

A Self-Administered Questionnaire to Measure Dependence on Cigarettes: The Cigarette Dependence Scale

• Jean-François Etter
• Jacques Le Houezec
• Thomas V Perneger

Clinical Research 14 Feb 2003

Caffeine Reversal of Ethanol Effects on the Multiple Sleep Latency Test, Memory, and Psychomotor Performance

• Christopher L Drake
• Timothy Roehrs
• Thomas Roth

Clinical Research 15 Jul 2002

Steroid Synthesis Inhibition with Ketoconazole and its Effect upon the Regulation of the Hypothalamus–Pituitary–Adrenal System in Healthy Humans

• Michael Deuschle
• Olivera Lecei
• Isabella Heuser

Clinical Research 12 Aug 2002

Treatment of Tourette Syndrome with Delta-9-Tetrahydrocannabinol (Δ⁹-THC): No Influence on Neuropsychological Performance

• Kirsten R Müller-Vahl
• Heidrun Prevedel
• Udo Schneider

Clinical Research 14 Feb 2003

Saccade and Cognitive Function in Chronic Kava Users

• Sheree Cairney
• Alan R Clough
• Jon Currie

Clinical Research 14 Feb 2003

A BDNF Coding Variant is Associated with the NEO Personality Inventory Domain Neuroticism, a Risk Factor for Depression

• Srijan Sen
• Randolph M Nesse
• Margit Burmeister

Clinical Research 29 Aug 2002

Synergistic Action of 5-HT_2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders

• Gerard J Marek
• Linda L Carpenter
• Lawrence H Price

Clinical Research 13 Sept 2002

Changes in Human In vivo Serotonin and Dopamine Transporter Availabilities during Chronic Antidepressant Administration

• Akira Kugaya
• Nicholas M Seneca
• Robert B Innis

Clinical Research 19 Jul 2002